Menu

• Ask a Health Expert about ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
• Post Your Side Effect related to ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY
• ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY and FDA Warnings
• ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY in Patients Wiki
• Report ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY in Drug Side Effect Survey

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY side effect

What is ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Neoral Side Effects Report #5607634-7
Physician from AUSTRALIA reported NEORAL problem on Jan 21, 2008. Male patient, 52 years of age, weighting 149.9 lb, was diagnosed with liver transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: biliary anastomosis complication, endoscopic retrograde cholangiopancreatography, hernia, hernia repair, postoperative fever, . NEORAL dosage: 125 MG, BID. During the same period patient was treated with PREDNISOLONE, AZATHIOPRINE. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5377244-8
FORTEO problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Female patient, 46 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct stent insertion, cholelithiasis, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, myalgia, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5377244-8
Consumer or non-health professional from UNITED STATES reported FORTEO problem on June 20, 2007. Female patient, 46 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bile duct stent insertion, cholelithiasis, endoscopic retrograde cholangiopancreatography, hepatic enzyme increased, myalgia, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.